C I Neutel1. Show Affiliations » 1. Bureau of Drug Surveillance, Therapeutic Products Program, Health Canada, Ottawa.
Abstract
Year: 1998 PMID: 15073739 DOI: 10.1002/(SICI)1099-1557(199803/04)7:2<131::AID-PDS337>3.0.CO;2-I
Source DB: PubMed Journal: Pharmacoepidemiol Drug Saf ISSN: 1053-8569 Impact factor: 2.890